GEN1
Flap endonuclease GEN homolog 1
Also known as: FLJ40869, Gen, GEN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q17RS7
- Gene
- GEN1
- Ensembl
- ENSG00000178295
- Chromosome
- 2
- Canonical length
- 908 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the Rad2/xeroderma pigmentosum group G nuclease family, whose members are characterized by N-terminal and internal xeroderma pigmentosum group G nuclease domains followed by helix-hairpin-helix domains and disordered C-terminal domains. The protein encoded by this gene is involved in resolution of Holliday junctions, which are intermediate four-way structures that covalently link DNA during homologous recombination and double-strand break repair. The protein resolves Holliday junctions by creating dual incisions across the junction to produce nicked duplex products that can be ligated. In addition, this protein has been found to localize to centrosomes where it has been implicated in regulation of centrosome integrity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
908 residues, UniProt reviewed canonical sequence.
>Q17RS7|GEN1
1 MGVNDLWQIL EPVKQHIPLR NLGGKTIAVD LSLWVCEAQT VKKMMGSVMK PHLRNLFFRI
61 SYLTQMDVKL VFVMEGEPPK LKADVISKRN QSRYGSSGKS WSQKTGRSHF KSVLRECLHM
121 LECLGIPWVQ AAGEAEAMCA YLNAGGHVDG CLTNDGDTFL YGAQTVYRNF TMNTKDPHVD
181 CYTMSSIKSK LGLDRDALVG LAILLGCDYL PKGVPGVGKE QALKLIQILK GQSLLQRFNR
241 WNETSCNSSP QLLVTKKLAH CSVCSHPGSP KDHERNGCRL CKSDKYCEPH DYEYCCPCEW
301 HRTEHDRQLS EVENNIKKKA CCCEGFPFHE VIQEFLLNKD KLVKVIRYQR PDLLLFQRFT
361 LEKMEWPNHY ACEKLLVLLT HYDMIERKLG SRNSNQLQPI RIVKTRIRNG VHCFEIEWEK
421 PEHYAMEDKQ HGEFALLTIE EESLFEAAYP EIVAVYQKQK LEIKGKKQKR IKPKENNLPE
481 PDEVMSFQSH MTLKPTCEIF HKQNSKLNSG ISPDPTLPQE SISASLNSLL LPKNTPCLNA
541 QEQFMSSLRP LAIQQIKAVS KSLISESSQP NTSSHNISVI ADLHLSTIDW EGTSFSNSPA
601 IQRNTFSHDL KSEVESELSA IPDGFENIPE QLSCESERYT ANIKKVLDED SDGISPEEHL
661 LSGITDLCLQ DLPLKERIFT KLSYPQDNLQ PDVNLKTLSI LSVKESCIAN SGSDCTSHLS
721 KDLPGIPLQN ESRDSKILKG DQLLQEDYKV NTSVPYSVSN TVVKTCNVRP PNTALDHSRK
781 VDMQTTRKIL MKKSVCLDRH SSDEQSAPVF GKAKYTTQRM KHSSQKHNSS HFKESGHNKL
841 SSPKIHIKET EQCVRSYETA ENEESCFPDS TKSSLSSLQC HKKENNSGTC LDSPLPLRQR
901 LKLRFQSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GEN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 14 nTPM
- tonsil: 11 nTPM
- lymph node: 10 nTPM
- epididymis: 8.7 nTPM
- skin: 7 nTPM
- rectum: 6.5 nTPM
Single-cell type
- choroid plexus epithelial cells: 269 nCPM
- retinal pigment epithelial cells: 119 nCPM
- monocyte progenitors: 85 nCPM
- sertoli cells: 82 nCPM
- cardiomyocytes: 65 nCPM
- gonadotrophs: 63 nCPM
Immune cell
- memory B-cell: 1.7 nTPM
- naive B-cell: 0.7 nTPM
- memory CD8 T-cell: 0.6 nTPM
- myeloid DC: 0.6 nTPM
- plasmacytoid DC: 0.6 nTPM
- T-reg: 0.5 nTPM
Brain region
- choroid plexus: 36 nTPM
- midbrain: 7.7 nTPM
- medulla oblongata: 7.1 nTPM
- spinal cord: 6.3 nTPM
- white matter: 6.3 nTPM
- hypothalamus: 6.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GEN1.
Disease | AutoantibodyPubMed
Conditions in which antibodies against GEN1 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for GEN1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
6 publications
- Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.
1988 · Ann Rheum Dis · RCR 1.1 · 35 citations - Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1.
1989 · Rheumatol Int · RCR 0.6 · 24 citations - Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
2020 · Lupus · RCR 0.6 · 11 citations - Autoantibodies to a novel early endosome antigen 1.
1998 · Clin Immunol Immunopathol · RCR 0.4 · 25 citations - Altered neurological function in mice immunized with early endosome antigen 1.
2004 · BMC Neurosci · RCR 0.2 · 10 citations
Show 1 more
- Clinical significance of human neutrophil antigen-1 antibodies in children with neutropenia.
2023 · Int J Hematol · RCR 0.2 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- double-strand break repair via homologous recombination
- positive regulation of mitotic cell cycle spindle assembly checkpoint
- regulation of centrosome duplication
- replication fork processing
- resolution of DNA recombination intermediates
- resolution of mitotic recombination intermediates
Molecular functions
- 5'-flap endonuclease activity
- crossover junction DNA endonuclease activity
- four-way junction DNA binding
- magnesium ion binding
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- XPG/Rad2 endonuclease
- XPG, N-terminal
- XPG-I domain
- Helix-hairpin-helix motif, class 2
- PIN-like domain superfamily
- 5'-3' exonuclease, C-terminal domain superfamily
- XPG N-terminal domain
- XPG I-region
- Flap endonuclease GEN, chromatin organization modifier domain
- Chromatin organization modifier domain 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GEN1 as an antibody target. Whether an autoantibody or antibody against GEN1 could matter depends on whether native GEN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GEN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GEN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...